TRIB1 has been reported to be associated with the occurrence and development of a variety of tumors, including leukemia [19], hepatocellular carcinoma [20], colorectal cancer [21], and prostate cancer [22]. This evidence concerns the gene TRIB1 and hepatocellular carcinoma.